Dr. Bob Ulrich is a General Partner and Managing Member of Vanguard Ventures, a venture capital firm focused on seed and early stage investments. Bob is a seasoned veteran of both the venture capital community and the health care industry, earning prominence as a technologist, operating executive, CEO, entrepreneur and venture capital investor.
He has been affiliated with Vanguard for nineteen of his twenty-two years in venture capital. During his career as a venture capitalist, he has been instrumental in raising over $400 million in funds for investment in life science and information technology start-ups, and has been responsible for over $200 million in life science investments that have created over $8 billion in value.
Bob has served as a Director of numerous private and public companies and as an advisor to other venture capital funds. He has also been the founding CEO of five start-up companies whose successes resulted in four acquisitions and one IPO.
Prior to that he spent 11 years in management roles in three major corporations; Johnson and Johnson, General Electric and Monsanto.
His current professional affiliations include; Director, Texas Life Science Center for Innovation and Commercialization of the Governor’s Texas Emerging Technology Fund; Director, Texas Nanotechnology Initiative; Member and past Director and Treasurer of the Houston Venture Capital Association; Chariman, BioHouston; and Lecturer in Management, Jones School of Business at Rice University.
Bob’s formal education is in the areas of physics (BA) and materials science (MS and PhD). He also attended GE’s “internal MBA” program at Crotonville, NY.